-SEC Filing
Related Posts
HC Wainwright & Co. Reiterates Buy on Actinium Pharmaceuticals, Maintains $53 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharmaceuticals (AMEX:ATNM) with a Buy and maintains $53 price target.
$1000 Invested In Arthur J. Gallagher 5 Years Ago Would Be Worth This Much Today
Arthur J. Gallagher (NYSE:AJG) has outperformed the market over the past 5 years by 14.6% on an annualized basis producing an average annual return of 26.05%. Currently, Arthur J. Gallagher has a market capitalization of $39.31 billion.
Viad Q2 EPS $(2.18) May Not Compare To $(0.77) Estimate, Sales $61.23M Beat $52.25M Estimate
Viad (NYSE:VVI) reported quarterly losses of $(2.18) per share which missed the analyst consensus estimate of $(0.77) by 183.12 percent. This is a 15.83 percent increase over losses of $(2.59) per share from the same